Sonavex (Series A+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$24,000,000
Company Info
Founders
David Narrow
Market
Healthcare & Wellness
Coinvestors
TEDCO (the State of Maryland Tech Arm),Texas Medical Center Venture Fund
Company Description

Real-time, definitive, visual and quantitative blood flow monitoring made possible with ultrasound. Sonavex is a developer of an imaging technology designed to visualize and quantify critical data to detect anastomotic blood clots.